ArticleDrugs in R&D2017

Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients.

José Antonio Mata-Marín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.